Category Archive

Treatment (Pharmaceutical)

Research into improving quality of life is most important to people with epilepsy: survey

November 3, 2016

By Deron Hamel Research programs aimed at enhancing quality of life for people with epilepsy are the most important avenue of research to those living with seizure disorders, their families and people working at epilepsy support agencies, according to a recent EpLink survey. EpLink’s “research priorities” online survey had 139 respondents. The survey, which was…

Epilepsy Ontario urging people to check Zarontin capsules after defects reported

September 30, 2016

By Deron Hamel Epilepsy Ontario is urging people taking 250-mg soft-gel capsules of the anti-seizure medication Zarontin (ethosuximide) to closely scrutinize their capsules to ensure they are not defective, following a warning issued by Erfa Canada 2012 Inc. and Health Canada. Erfa Canada 2012 Inc., the company that manufactures Zarontin, and Health Canada have received…

Gov’t needs to take a proactive response to stem drug shortages: Epilepsy Ontario

May 19, 2016

By Deron Hamel One of the greatest frustrations Epilepsy Ontario deals with during shortages of seizure-control medications is when impending drug shortages are identified but Health Canada and the provincial drug programs do nothing to try to prevent them, says Suzanne Nurse. Nurse, Epilepsy Ontario’s director of information and client services, says that 2016 has…